Recombinant adenovirus expressing a dendritic cell-targeted melanoma surface antigen for tumor-specific immunotherapy in melanoma mice model

Experimental and Therapeutic Medicine
Li-Li GuoLin-Bo Liu

Abstract

Viral vectors represent a potential strategy for the treatment of human malignant tumors. Currently, recombinant adenovirus vectors are commonly used as gene therapy vehicles, as it possesses a proven safety profile in normal human cells. The recombinant adenovirus system has an ability to highly express exogenous genes and increase the stability of the carrier, which is only transiently expressed in the host cell genome, without integrating. Malignant melanoma cells are produced by the skin, and melanocyte tumors that exhibit higher malignant degrees lead to earlier transfer and higher mortality. In the present study, a recombinant adenovirus (rAd) was generated to express Anti-programmed death-1 (rAd-Anti-PD-1) and used to investigate the efficacy in melanoma cells and tumors. The results demonstrated that B16-F10 cell growth was significantly inhibited and the apoptosis incidence rate was markedly promoted following rAd-PD-1 treatment. The present study demonstrated that the production of α and β interferon was increased, which led to the induction of dendritic cell (DCs) maturation in rAd-anti-PD-1-treated mice. The present study indicated that rAd-anti-PD-1 exhibited the ability to generate more cluster of differentiation ...Continue Reading

References

May 21, 1998·Nature Biotechnology·W DebinskiR K Puri
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 6, 2003·Preparative Biochemistry & Biotechnology·Hiroyuki Shiono, Yoichiro Ito
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A D SantinS Pecorelli
May 15, 2004·Cancer Letters·Axel GerhardtStefan Eichmüller
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeremy P BraybrookeAdrian L Harris
Dec 24, 2008·Archivum Immunologiae Et Therapiae Experimentalis·Joseph G Sinkovics, Joseph C Horvath
Feb 1, 2012·The Cancer Journal·Alissa A ThomasCamilo E Fadul
Aug 10, 2012·Molecular Biology of the Cell·Maryline AllegraGeorge Mavrothalassitis
Oct 9, 2012·Cancer·Robert Ferris
Dec 20, 2012·Virology Journal·Rasmus K L GustafssonAnna Fogdell-Hahn
Mar 13, 2015·Biomedit︠s︡inskai︠a︡ khimii︠a︡·Zh K Nazarkina, P P Laktionov
Nov 12, 2015·European Journal of Nuclear Medicine and Molecular Imaging·A Martínez-EsteveI Borrego-Dorado
Nov 18, 2015·Pigment Cell & Melanoma Research·Alex Cazes, Ze'ev A Ronai
Jan 26, 2016·The Journal of Clinical Investigation·Matthias LeisegangThomas Blankenstein
Feb 13, 2016·Journal of Oncology Practice·Stephen M Ansell
Feb 27, 2016·Recent Patents on Anti-cancer Drug Discovery·Xiao-Na Fang, Li-Wu Fu
Mar 17, 2016·Melanoma Research·Steven P LudlowEboné Hill
Mar 31, 2016·Medicina clínica·Renata LinertováJuan Ramón Lacalle-Remigio
May 31, 2016·Medical Ultrasonography·Loredana UngureanuSimona Corina Șenilă
Jun 3, 2016·Journal of Cutaneous Pathology·Gaurav SharmaNageatte Ibrahim
Jun 12, 2016·Journal of Oncology Practice·Ugonma ChukwuekePriscilla Brastianos
Jun 12, 2016·Journal of Oncology Practice·Kim A Margolin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.